?:authorAffiliation
|
-
[\'Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany. Electronic address: robert.markewitz@uksh.de.\', \'Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany.\', \'Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel & University Hospital Schleswig-Holstein, Kiel, Germany.\', \'Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, San Sebastián, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, \'Instituto de Salud Carlos III\'), University of the Basque Country (UPV/EHU), San Sebastián, Spain.\', \'Biodonostia Health Research Institute, Infectious Diseases Area, Respiratory Infection and Antimicrobial Resistance Group, Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Microbiology Department, San Sebastián, Spain.\', \'Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, San Sebastián, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, \'Instituto de Salud Carlos III\'), University of the Basque Country (UPV/EHU), San Sebastián, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.\', \'Osakidetza, OSI Donostialdea, Altza Primary Care; Biodonostia Health Research Institute, San Sebastián, Spain.\', \'Clinical Biochemistry Department, Biodonostia Health Research Institute Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation. San Sebastián, Spain.\']
|